Memphasys Ltd

As of June 30, 2024, Memphasys Ltd carries a market capitalization of 6.00M, placing it among publicly traded companies globally. Its enterprise value stands at 8.82M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2024, Memphasys Ltd has 1.38B shares outstanding.

These figures are as of June 30, 2024. The price-to-sales ratio is 268.38, and the price-to-book ratio stands at 1.41.

These figures are as of June 30, 2024. The EV/Sales ratio of 236.14 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 8.82M versus a market cap of 6.00M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2024, Memphasys Ltd maintains a current ratio of 0.31, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 70.33, indicating elevated leverage, while an interest coverage ratio of -14.19 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2024, Memphasys Ltd posted a negative return on equity (ROE) of -62.46, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -32.78, reflecting losses generated across the asset base. Inventory turnover of 0.40 indicates how many times Memphasys Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Memphasys Ltd's stock has gained approximately 33.33% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Over the twelve months ended June 30, 2024, Memphasys Ltd generated 37,356.38 in revenue and converted that into -2.77M in net income, yielding earnings per share of 0.00. EBITDA reached -2.82M, while operating income came in at -3.26M.

As of June 30, 2024, Memphasys Ltd holds 172,961.26 in cash and equivalents against 2.99M in total debt, resulting in a net debt position of 2.57M. Total book value stands at 4.26M, with working capital of -2.26M providing operational flexibility.

These figures cover the twelve months ended June 30, 2024.

Over the twelve months ended June 30, 2024, Memphasys Ltd posted a gross margin of 2.68, reflecting its pricing power and cost economics. The operating margin of -8,731.22 and net profit margin of -7,403.37 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2024. Total shareholder yield is negative at -36.73, meaning Memphasys Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Memphasys Ltd's most recent stock split took place on October 6, 2025 with a 27:28 split ratio.

As of June 30, 2024, Memphasys Ltd has an Altman Z-Score of -38.36, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.